Stock vs Stock Comparison

Arcosa, Inc. vs GE Vernova Inc.

GEV wins the Tale of the Tape 5–4.

ACA
GEV$959.36

🏆 Tale of the Tape

45
ACAGEV
7.2%Profitability (Net Margin)12.8%
28.3xValuation (P/E)28.3x
6.2%Efficiency (ROIC)5.0%
8/9Health (Piotroski F)6/9
Safety (Altman Z)4.0
12.2%Growth (Rev YoY)9.0%
Risk (Sharpe 1Y)2.51
0.89xBalance Sheet (D/E)4.12x
FCF Yield1.43%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Fundamentals

MetricACAGEV
Market Cap$5.9B$260.2B
P/E Ratio28.3x28.3x
Forward P/E22.4x39.5x
P/B2.23x18.69x
Dividend Yield0.17%0.21%
Beta0.961.31

Quantitative Metrics

MetricACAGEV
DCF Fair Value$99.96$382.10
DCF Upside-61.5%
Piotroski F8/96/9
Altman Z3.96
Beneish M-2.48-2.32
FCF Yield1.43%
Net Debt/EBITDA2.3x-3.8x
ROIC6.2%5.0%
WACC12.2%
ROIC – WACC-7.2pp
Gross Margin22.4%19.8%
Net Margin7.2%12.8%
Rev Growth YoY12.2%9.0%
Sharpe (1Y)2.51
Max Drawdown 3Y
FCF Payout Ratio6%7%

ACA Price

Loading chart...

GEV Price

Loading chart...

ETF Exposure

ACA found in:

SLYG0.45%
SPSM0.35%
SLYV0.25%
VTWO0.18%
VFMO0.15%
VBR0.14%
VGK0.12%
VYMI0.10%
VIS0.09%
SPDW0.08%
VB0.08%
VXF0.08%
VEA0.06%
VSGX0.06%
CWI0.05%
VEU0.05%
VXUS0.04%
SPTM0.01%

GEV found in:

XLI5.29%
VIS4.16%
IYJ3.69%
RDVY3.13%
MGK1.24%
VFMO1.13%
VONG0.94%
SCHG0.90%
VUG0.86%
IWF0.85%
SPYG0.80%
VOO0.47%
SPY0.44%
VONE0.44%
VTI0.42%
SPTM0.41%
SCHX0.38%
SCHB0.36%
IVV0.30%
URTH0.28%
ITOT0.27%
SPLG0.27%
VT0.26%
ONEO0.24%
ACWI0.21%
RSP0.20%
QUS0.12%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

ACA vs GEV: Head-to-Head Analysis

Arcosa, Inc. (ACA) and GE Vernova Inc. (GEV) represent two companies in the Industrials sector. In our quantitative Tale of the Tape scoring, GEV leads 5–4 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, ACA generates a return on invested capital (ROIC) of 6.2% compared to GEV's 5.0%. This suggests ACA is more effective at deploying capital to generate shareholder returns.

ACA appears in 18 ETFs tracked by SecuritiesDB, while GEV appears in 27 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, ACA or GEV?

Our quantitative analysis compares ACA and GEV across nine fundamental dimensions. GEV wins the Tale of the Tape 5–4. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are ACA and GEV correlated?

Correlation data is not yet available for this pair. Check back after both stocks have sufficient trading history.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.